North America's e-Cigarette Market Set to Explode at 18.2% CAGR, Reaching $31.3 Billion by 2028 - Market Shares by Product Type, Flavor Variation, Battery Operation Mode, and Distribution Channel Unveiled
31. Januar 2024 03:59 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "North America e-Cigarette Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global E-Cigarette Markets, 2021-2022 & 2027: Shift towards Next Generation Products, Upswing in Gen Z Income, Rise in Technological Developments
13. September 2022 05:33 ET
|
Research and Markets
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The "Global E-Cigarette Market: By Product Type, By Category, By Composition, By Distribution Channel, By Region Size & Forecast with Impact Analysis...
Insights on the E-Cigarette Global Market to 2027 - by Product, Flavor, Mode of Operation, Distribution Channel and Region
06. April 2022 07:58 ET
|
Research and Markets
Dublin, April 06, 2022 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global E-Cigarette Market Report 2021: Consumer Perception of a Safer Product v Traditional Cigarettes has Led to Increased Demand
22. April 2021 07:48 ET
|
Research and Markets
Dublin, April 22, 2021 (GLOBE NEWSWIRE) -- The "E-Cigarette Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...
Rapid Therapeutic Announces Completion of New ISO 13485 Laboratory
18. August 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented aerosol manufacturing and marketing company focused on...
Rapid Therapeutic Science Laboratories (RTSL), Inc. engages Ezzey Digital Marketing Agency to Launch its New Lifestyle Brand “nhāler”
06. August 2020 07:00 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Completes Delivery of Additional 6,000 Units of its Proprietary Metered Dose Inhalers
14. Juli 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 14, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented manufacturing and marketing company focused on employing...
Rapid Therapeutic Announces Major Contract is Increased by 150% to 250,000 Metered Dose Inhalers
09. Juli 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 09, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL), a fully-reporting, early stage, emerging biotech company focused on aerosol delivery of...
Rapid Therapeutic Completes Initial Delivery of 2,000 Units of its Proprietary Metered Dose Inhalers
08. Juli 2020 07:30 ET
|
Rapid Therapeutic Science Laboratories, Inc. (OTC:RTSL)
DALLAS, July 08, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing aerosol...
Rapid Therapeutic Science Laboratories, Inc. Highlighted in Research Report Released by Emerald Equity Research, LLC
22. Juni 2020 08:30 ET
|
Rapid Therapeutic Science Laboratories
DALLAS, June 22, 2020 (GLOBE NEWSWIRE) -- Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) an SEC fully-reporting, growth-oriented company focused on manufacturing and marketing CBD aerosol...